Epidemiological Characteristics of Newly Diagnosed Cases of HIV through Injection Drug Use — China, 2012–2019

What is already known about this topic? The annual rates of newly diagnosed cases of human immunodeficiency virus (HIV) are increasing in China, yet the annual number of newly diagnosed cases of HIV infected through injection drug use (IDU) is decreasing. What is added by this report? Newly diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Houlin, Cai, Chang, Cui, Yan, Qin, Qianqian, Lyu, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422365/
https://www.ncbi.nlm.nih.gov/pubmed/34594801
http://dx.doi.org/10.46234/ccdcw2020.251
Descripción
Sumario:What is already known about this topic? The annual rates of newly diagnosed cases of human immunodeficiency virus (HIV) are increasing in China, yet the annual number of newly diagnosed cases of HIV infected through injection drug use (IDU) is decreasing. What is added by this report? Newly diagnosed cases of HIV infected through IDU in China from 2012 to 2019 show decreases year over year, but the risk of new infections through injecting drugs still exists. What are the implications for public health practice? This study highlighted that new HIV infections through IDU continue to be at a low level. However, individuals that are newly diagnosed as HIV-positive through IDU need to have their baseline CD4 T+ lymphocytes (CD4) cell counts monitored and have their sources of infections traced.

Ejemplares similares